TD Asset Management Inc

Position in PHVS — Pharvaris N.V.

CIK 1056053 Toronto, A6

Position in PHVS

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$1,548,834

-$1,788,048 QoQ

Shares Held

54,826

-54.4% QoQ

Ownership

0.078%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

TD Asset Management Inc holds $1,314,505,240 across 121 Biotechnology names. PHVS ranks #86 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	350,923	$271,137,146
2	VRTX	Vertex Pharmaceuticals Inc / Ma	228,195	$101,898,194
3	ALNY	Alnylam Pharmaceuticals, Inc.	281,848	$93,255,047
4	HALO	Halozyme Therapeutics, Inc.	1,168,666	$75,530,883
5	ARGX	Argenx SE	80,824	$59,021,726
6	ASND	Ascendis Pharma A/S	217,992	$49,861,310
7	IONS	Ionis Pharmaceuticals Inc	529,954	$39,794,245
8	RVMD	Revolution Medicines, Inc.	317,811	$30,907,119

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,548,834	54,826	-54.4%	Shares	Sole	2026-05-11
2025-12-31	$3,336,882	120,248	+15.2%	Shares	Sole	2026-02-10
2025-09-30	$2,603,682	104,356	+4.9%	Shares	Sole	2025-11-10
2025-06-30	$1,751,376	99,510	+27.4%	Shares	Sole	2025-07-28
2025-03-31	$1,226,515	78,122	+41.5%	Shares	Sole	2025-05-07
2024-12-31	$1,058,490	55,216	+52.5%	Shares	Sole	2025-02-11
2024-09-30	$670,720	36,216	-57.8%	Shares	Sole	2024-11-01
2024-06-30	$1,613,340	85,816	-23.8%	Shares	Sole	2024-08-02
2024-03-31	$2,602,555	112,616	—	Shares	Sole	2024-05-08
No filing history on record for this holder in this stock.